Literature DB >> 8881900

Treatment of severe atopic dermatitis in childhood with cyclosporin.

I Zaki1, R Emerson, B R Allen.   

Abstract

Cyclosporin has been shown to be effective in the treatment of adult atopic dermatitis, but there are no clinical trials evaluating its use in childhood. Atopic dermatitis is more common in children and the severe form can be associated with considerable morbidity. We report on 18 children with severe refractory atopic dermatitis who have been treated with cyclosporin on an open basis. The drug was given at an initial daily dose of 5 or 6 mg/kg and in some patients the dose was reduced according to response. Sixteen patients showed a good or excellent response to treatment, one a moderate response and one patient failed to improve. The treatment was well tolerated and there were no significant changes in serum creatinine or blood pressure. Long remission after withdrawal of treatment was seen in some patients, although most relapsed within a few weeks. We suggest that cyclosporin is an effective and safe short-term treatment for severe atopic dermatitis in childhood.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8881900     DOI: 10.1111/j.1365-2133.1996.tb00705.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  6 in total

Review 1.  Psoriasis in children: a guide to its diagnosis and management.

Authors:  J Leman; D Burden
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 2.  Recent advances in treatment strategies for atopic dermatitis.

Authors:  Thomas Christian Roos; Stefan Geuer; Sabine Roos; Harald Brost
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 3.  Narrative review on the management of moderate-severe atopic dermatitis in pediatric age of the Italian Society of Pediatric Allergology and Immunology (SIAIP), of the Italian Society of Pediatric Dermatology (SIDerP) and of the Italian Society of Pediatrics (SIP).

Authors:  Elena Galli; Anna Belloni Fortina; Giampaolo Ricci; Nunzia Maiello; Iria Neri; Ermanno Baldo; Irene Berti; Domenico Bonamonte; Lucetta Capra; Elena Carboni; Rossella Carello; Francesca Caroppo; Giovanni Cavagni; Iolanda Chinellato; Francesca Cipriani; Pasquale Comberiati; Andrea Diociaiuti; Vito Di Lernia; Marzia Duse; Cesare Filippeschi; Arianna Giannetti; Mattia Giovannini; Amelia Licari; Gian Luigi Marseglia; Manuela Pace; Annalisa Patrizi; Giovanni Battista Pajno; Diego Peroni; Alberto Villani; Lawrence Eichenfield
Journal:  Ital J Pediatr       Date:  2022-06-14       Impact factor: 3.288

4.  Methotrexate versus cyclosporine in the treatment of severe atopic dermatitis in children: a multicenter experience from Egypt.

Authors:  Mohamed A El-Khalawany; Hatem Hassan; Dalia Shaaban; Noha Ghonaim; Bayoumi Eassa
Journal:  Eur J Pediatr       Date:  2012-11-16       Impact factor: 3.183

Review 5.  Treatment of atopic dermatitis and impact on quality of life: a review with emphasis on topical non-corticosteroids.

Authors:  Roman Schiffner; Julia Schiffner-Rohe; Michael Landthaler; Wilhelm Stolz
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

6.  Validation of treatment escalation as a definition of atopic eczema flares.

Authors:  Kim S Thomas; Beth Stuart; Caroline J O'Leary; Jochen Schmitt; Carle Paul; Hywel C Williams; Sinead Langan
Journal:  PLoS One       Date:  2015-04-21       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.